Qiagen N.V. (QGEN)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 46.35 |
| Open | 46.57 |
| Bid | 40.00 x 800 |
| Ask | 56.00 x 900 |
| Day's range | 45.88 - 46.92 |
| 52-week range | 41.32 - 58.00 |
| Volume | |
| Avg. volume | 757,056 |
| Market cap | 10.438B |
| Beta (5Y monthly) | 0.28 |
| PE ratio (TTM) | 19.79 |
| EPS (TTM) | 2.32 |
| Earnings date | 25 Jul 2022 - 29 Jul 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 52.53 |
- Zacks
QIAGEN (QGEN) to Acquire Poland-Based Enzymes Manufacturer
The latest acquisition of BLIRT will allow QIAGEN (QGEN) to tap into the high opportunities within the life science industry.
- Business Wire
QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced Panels
HILDEN, Germany & GERMANTOWN, Md., May 16, 2022--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAstat-Dx Rise – a high-capacity version of the QIAstat-Dx automated syndromic system – and enhancements to the menu of tests for the fully integrated one-step molecular testing solution that provides results in about one hour.
- Simply Wall St.
What Type Of Shareholders Own The Most Number of Qiagen N.V. (NYSE:QGEN) Shares?
If you want to know who really controls Qiagen N.V. ( NYSE:QGEN ), then you'll have to look at the makeup of its share...
© 2022 Yahoo. All rights reserved.
